Evidence map›Paper›PMID 31552040›Full record

ArticleFrontiers in immunology2019

Vitamin D in Acute Campylobacteriosis-Results From an Intervention Study Applying a Clinical

Soraya Mousavi, Fábia Daniela Lobo de Sá, Jörg-Dieter Schulzke, Roland Bücker, Stefan Bereswill, Markus M Heimesaat

Abstract read
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Therapeutic and protective approaches to combatFrontiers in pharmacology · 2025
    Review
  2. Article
  3. Molecular Targets inBiomolecules · 2023
    Review
  4. Article
  5. Vitamin D Reverses Disruption of Gut Epithelial Barrier Function Caused byInternational journal of molecular sciences · 2021
    Article
  6. Article
  7. Article
  8. Treatment with the Probiotic Product AviguardInternational journal of molecular sciences · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Resveratrol PreventsFrontiers in pharmacology · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Resveratrol Alleviates AcuteMicroorganisms · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Soraya MousaviInstitute of Microbiology, Infectious Diseases and Immunology, Charité - University Medicine Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Fábia Daniela Lobo de SáInstitute of Clinical Physiology, Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Jörg-Dieter SchulzkeInstitute of Clinical Physiology, Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Roland BückerInstitute of Clinical Physiology, Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Stefan BereswillInstitute of Microbiology, Infectious Diseases and Immunology, Charité - University Medicine Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Markus M HeimesaatInstitute of Microbiology, Infectious Diseases and Immunology, Charité - University Medicine Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human

Indexed as

Campylobacter jejuniAcute DiseaseAnimalsAnti-Inflammatory AgentsCalcifediolCampylobacter InfectionsCytokinesEnterocolitisFemaleGastrointestinal TractMaleMice, KnockoutVitaminsAnti-Inflammatory AgentsCalcifediolCytokinesVitaminsacute enterocolitiscampylobacteriosis modelCampylobacter jejunihost-pathogen interactionintervention studyintestinal epithelial barrier functionvitamin D

Identifiers

PMID31552040
PMCPMC6735268

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.